Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-1-5
pubmed:abstractText
The criteria for the use of mild hypothermia (34 degrees C) in severely head injured patients have not been standardized. A prospective randomized controlled trial was conducted to determine whether mild hypothermia is essential in the treatment of severely head injured patients with low intracranial pressure (ICP).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-3085
pubmed:author
pubmed:issnType
Print
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
50-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11147897-Adolescent, pubmed-meshheading:11147897-Adult, pubmed-meshheading:11147897-Aged, pubmed-meshheading:11147897-Blood Pressure, pubmed-meshheading:11147897-Cerebrovascular Circulation, pubmed-meshheading:11147897-Child, pubmed-meshheading:11147897-Child, Preschool, pubmed-meshheading:11147897-Craniocerebral Trauma, pubmed-meshheading:11147897-Female, pubmed-meshheading:11147897-Humans, pubmed-meshheading:11147897-Hypothermia, Induced, pubmed-meshheading:11147897-Infant, pubmed-meshheading:11147897-Infant, Newborn, pubmed-meshheading:11147897-Intracranial Pressure, pubmed-meshheading:11147897-Male, pubmed-meshheading:11147897-Middle Aged, pubmed-meshheading:11147897-Prospective Studies, pubmed-meshheading:11147897-Severity of Illness Index, pubmed-meshheading:11147897-Treatment Failure
pubmed:year
2001
pubmed:articleTitle
A multicenter prospective randomized controlled trial of the efficacy of mild hypothermia for severely head injured patients with low intracranial pressure. Mild Hypothermia Study Group in Japan.
pubmed:affiliation
Department of Traumatology, Osaka University Medical School, Kinki University School of Medicine, Japan. shiozaki@hp-emerg.med.osaka-u.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study